What is Zometa (zoledronic acid)?
Zometa is a brand name for a medicine whose active ingredient is zoledronic acid — a potent member of the group of medicines called bisphosphonates. Unlike vitamin infusions, Zometa is a genuine medicine that is prescribed and administered only on the basis of a medical indication and prescription.
Our bones are constantly renewing themselves — old bone cells are broken down and new ones are formed. In osteoporosis and some other conditions this balance is disturbed, so bone is broken down faster than it is renewed, loses density and becomes prone to fractures. Zoledronic acid slows the breakdown of bone and thus helps the bone remain stronger.
Zometa is given intravenously, as an infusion, usually at longer intervals (in osteoporosis most often once a year, and on a special schedule for other indications). The exact medicine, dose and dynamics are always determined by the doctor managing your treatment.
At Medical Time, Zometa is administered responsibly and strictly medically — with a check that all conditions for safe administration are met, with preparation before the infusion and clear instructions for the period after it.
Who Zometa is for and its indications
Zometa is administered in conditions in which bone needs to be strengthened or its breakdown slowed, always on the basis of a medical assessment and appropriate diagnostics (such as bone density measurement — densitometry — and laboratory findings).
The most common indications for zoledronic acid are:
The decision on whether you need Zometa, in what dose and with what dynamics, is made solely by the doctor — based on the findings, your general condition and other medicines you take.
- osteoporosis in postmenopausal women and in men, to reduce the risk of fractures
- osteoporosis caused by long-term use of corticosteroids
- Paget's disease of bone
- certain bone complications as part of oncological treatment, at the oncologist's decision
- conditions of raised blood calcium linked to an underlying disease, at the doctor's assessment
- continuation of previously started bisphosphonate therapy, according to the doctor's plan
Composition and how it works
The active ingredient of the medicine is zoledronic acid, supplied in the form of a solution for intravenous infusion, ready for administration in controlled conditions. The dose and concentration depend on the indication and are prescribed for the specific purpose.
Zoledronic acid acts specifically on bone tissue:
- binds to bone and slows the work of the cells that break down bone tissue (osteoclasts)
- thereby reduces excessive loss of bone mass
- helps preserve the density and strength of bone
- in osteoporosis contributes to reducing the risk of fractures
- in certain bone complications helps control the disease, as part of broader treatment
Why preparation and replacement of calcium and vitamin D matter
For the therapy to be safe and effective, before Zometa is administered it is important that the blood calcium level is normal and that vitamin D stores are not low. That is why, before the infusion, the doctor checks the findings and, if needed, recommends replacement of calcium and vitamin D.
It is also recommended that, before starting therapy, you have a dental examination and address any dental problems, as this further reduces the risk of rare complications related to the jaw.
What the procedure looks like — course, duration and medical supervision
Before the infusion the doctor checks the indication, the findings of kidney function and calcium, and confirms that the conditions for safe administration are met. It is very important to be well hydrated before the infusion, so it is recommended to drink enough fluids.
The infusion is received comfortably, in a seated or lying position. A nurse places a venous cannula, and the zoledronic acid solution is delivered slowly into the vein. Slow administration is important for safety — zoledronic acid is never given in a hurry.
The infusion itself usually takes at least 15 minutes, and often longer, depending on the preparation and instructions. After administration a short rest under supervision is recommended. The therapy is, depending on the indication, repeated at longer intervals — in osteoporosis usually once a year.
At Medical Time, Zometa is always given in controlled, medical conditions, with trained staff and a doctor available throughout the procedure, with clear instructions for the period after the infusion.
Safety and side effects
Zoledronic acid is an effective medicine that is, with correct administration and supervision, well tolerated. Still, like any medicine, it can have side effects that it is important to discuss in advance.
The most common side effects, especially after the first infusion, are usually transient:
- a flu-like reaction in the first days after the infusion — raised temperature, muscle and joint pain, fatigue (most often after the first administration and increasingly mild with subsequent ones)
- headache and transient nausea
- a transient drop in blood calcium — which is why replacement of calcium and vitamin D matters
- discomfort or redness at the puncture site
- very rarely: kidney problems in predisposed people — which is why hydration and a check of kidney function are mandatory
- very rarely: osteonecrosis of the jaw (especially with dental problems) and atypical fractures with long-term use
How the risks are kept to a minimum
The flu-like reaction is eased by good hydration and, on the doctor's advice, a pain and fever medicine. The risk to the kidneys is reduced by fluid intake and a check of kidney function before administration, and the risk to the jaw by good oral hygiene and a dental examination before starting therapy.
This is precisely why Zometa is given only under medical supervision and with clear instructions — so that the benefit to the bones is as great as possible, and the risks are kept to the lowest possible level.
Contraindications — when the infusion is not recommended
There are conditions in which Zometa is not given, or is given only with particular caution. That is why a medical assessment, findings and preparation before administration are mandatory.
Particular caution, or refraining from the infusion, applies especially to:
- a low blood calcium level (hypocalcaemia) — must be corrected first
- seriously impaired kidney function
- known hypersensitivity to zoledronic acid or other bisphosphonates
- pregnancy and breastfeeding
- unaddressed dental problems and planned major dental procedures — to be coordinated with the doctor
- insufficiently replaced vitamin D — preferably corrected before therapy
Why receive a Zometa infusion at Medical Time
At Medical Time, Zometa is administered strictly medically and responsibly — with a check of the findings, preparation, good hydration and supervision during administration, in the controlled conditions of a hospital in Belgrade. Bone therapy is not a routine infusion, and we treat it accordingly.
Everything needed is available to you in one place — from laboratory tests and an assessment, through the infusion itself, to clear instructions and check-ups with which we monitor the course of treatment.
- administration only with a doctor's prescription and an assessment of the indication
- a check of kidney function and calcium before every administration
- preparation, hydration and a slow, controlled pace of administration
- trained staff and supervision throughout the procedure
- clear instructions for the period after the infusion and monitoring of therapy
- laboratory and medical assessment available in the same place
Price — Zometa infusion
The price of a Zometa infusion depends on the preparation and the prescribed dose of zoledronic acid, on the administration of the infusion service itself, and on the laboratory tests and medical assessment that precede therapy. As this is a prescription medicine, administration is planned in agreement with the doctor. You receive the exact price and an appointment quickly, by phone or through the contact form.
- Zometa infusion — administration under supervision (administration service)
- Laboratory tests and medical assessment before therapy
- Follow-up examination and monitoring of therapy
For the current price and an appointment call 062-399-888 or contact us.
Frequently asked questions about the Zometa infusion
Zometa is a medicine whose active ingredient is zoledronic acid, from the bisphosphonate group. It is used to strengthen bones and slow their breakdown — in osteoporosis, Paget's disease and certain bone complications — always on the basis of a medical assessment and prescription.
It depends on the indication. In osteoporosis it is most often given once a year, while in other conditions it is administered on a special schedule. The dynamics are always determined by the doctor managing the treatment.
The infusion itself is given slowly and usually takes at least 15 minutes, and often longer, depending on the preparation and instructions. After administration a short rest under supervision is recommended.
Yes, a flu-like reaction — raised temperature, muscle and joint pain and fatigue — is common in the first days, especially after the first infusion. It is usually transient, eased by hydration and a pain medicine on the doctor's advice, and increasingly mild with subsequent administrations.
Good hydration before and after the infusion protects the kidneys, as zoledronic acid is excreted through them. That is why it is recommended to drink enough fluids before administration, and the doctor also checks kidney function before the infusion.
Yes, a dental examination and addressing dental problems before starting bisphosphonate therapy are recommended, as this reduces the risk of a rare complication of the jaw (osteonecrosis). Inform the doctor of any planned major dental procedures.
Yes. Zometa is a prescription medicine and is given only on the basis of a medical assessment. Before administration appropriate findings are needed, including kidney function and calcium level, as well as replacement of calcium and vitamin D if needed.
No. Zometa slows the breakdown of bone, but sufficient intake of calcium and vitamin D is still needed for bone health. The doctor will recommend appropriate replacement alongside the therapy.